BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38169835)

  • 1. Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.
    Yuan Y; Zhang D; Ning Y; Luo H; Qiu X; Tan Y; Li Y; Yang X
    Front Oncol; 2023; 13():1257528. PubMed ID: 38169835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of robotic retroperitoneal lymph node dissection in testicular cancer: a systematic review and meta-analysis.
    Ge S; Zeng Z; Li Y; Gan L; Meng C; Li K; Wang Z; Zheng L
    Int J Surg; 2023 Sep; 109(9):2808-2818. PubMed ID: 37222676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the perioperative outcomes of laparoscopic and open retroperitoneal lymph node dissection for low-stage (stage I/II) testicular germ cell tumors: a systematic review and meta-analysis.
    Ge S; Gan L; Meng C; Li K; Wang Z; Zeng Z; Zheng L; Li Y
    Int J Surg; 2023 Apr; 109(4):995-1005. PubMed ID: 36917132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer.
    Chavarriaga J; Atenafu EG; Mousa A; Langleben C; Anson-Cartwright L; Jewett M; Hamilton RJ
    Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38278693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
    Garg H; Mansour AM; Psutka SP; Kim SP; Porter J; Gaspard CS; Dursun F; Pruthi DK; Wang H; Kaushik D
    BJU Int; 2023 Jul; 132(1):9-30. PubMed ID: 36754376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes.
    Shishido T; Okegawa T; Hayashi K; Masuda K; Taguchi S; Nakamura Y; Tambo M; Fukuhara H
    Asian J Urol; 2022 Apr; 9(2):119-124. PubMed ID: 35509484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
    Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
    World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Harris KT; Gorin MA; Ball MW; Pierorazio PM; Allaf ME
    BJU Int; 2015 Dec; 116(6):920-3. PubMed ID: 25781349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Hillelsohn JH; Duty BD; Okhunov Z; Kavoussi LR
    Arab J Urol; 2012 Mar; 10(1):66-73. PubMed ID: 26558006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
    Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
    Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
    Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
    Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre.
    Grenabo Bergdahl A; MÃ¥nsson M; Holmberg G; Fovaeus M
    BJUI Compass; 2022 Sep; 3(5):363-370. PubMed ID: 35950045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic versus Laparoscopic Retroperitoneal Lymph node Dissection for Clinical Stage I Non-seminomatous Germ Cell Tumor of Testis: A Comparative Analysis.
    Xu Y; Li H; Wang B; Gu L; Gao Y; Fan Y; Yao Y; Fam X; Ma X; Zhang X
    Urol J; 2021 Oct; 18(6):618-622. PubMed ID: 34606083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
    Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA
    J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
    Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
    World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.